© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
American Academy of Neurology Annual Meeting
Optimizing Treatment in Acute Migraine: Stephanie J. Nahas, MD
May 07, 2021
The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University detailed the ways clinicians can tailor their treatment regimens better.
Remote Screening for Cognitive Impairment: Richard Gershon, PhD
May 06, 2021
The vice chair for research at the Northwestern University Feinberg School of Medicine discussed the Mobile Toolbox Battery that his team developed.
Gaps in Access to Device-Aided Therapies for Parkinson Disease: Hubert Fernandez, MD
May 06, 2021
The director of the Center for Neurological Restoration at Cleveland Clinic spoke to how identifying care gaps in Parkinson disease patients is not a niche issue, but part of a bigger problem.
Nipocalimab in Myasthenia Gravis and the Remaining Needs for Patients
May 06, 2021
Jeffrey Guptill, MD, MS, MHS, associate professor of neurology at neurologist at Duke University, detailed early positive results for nipocalimab in myasthenia gravis and the urgency to provide more treatment options for patients.
Diagnosis Through Teleneurology: Jason Poon, MD
May 05, 2021
The neurologist at University of Utah discussed the potential of using teleneurology to diagnose neurological conditions.
Data-Driven Categorization of Patients With Multiple Sclerosis: Daniel Ontaneda, MD, PhD
May 05, 2021
The associate professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University discussed the findings of his presentation at AAN 2021.
NeuroVoices: Vineet Punia, MD, MS, on Responsive Neurostimulation in Older Adults
May 05, 2021
The neurologist from Cleveland Clinic discussed his study presented at AAN 2021 involving the use of responsive neurostimulation in older adults with drug-resistant focal epilepsy and further expanding research in this space.
Understanding Fenfluramine’s Impact on Executive Function in Lennox-Gastaut Syndrome
May 04, 2021
Kim Bishop, PhD, and Arnold Gammaitoni, PharmD, discussed the ways fenfluramine impacts not only seizure frequency, but executive function in individuals with Lennox-Gastaut syndrome.
Advantages of Atogepant in Ever-Growing CGRP Market: Lawrence Severt, MD, PhD
May 04, 2021
The director at AbbVie highlighted where atogepant stands among the increasing treatment landscape of anti-calcitonin gene-related peptide options within the migraine treatment landscape.
Biomechanical Measures of Upper Extremity Function in MS: Marisa McGinley, DO
May 04, 2021
The staff neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic spoke to a study using the digital Manual Dexterity Test.